Belupo s.r.o.
PolandAll drugs from this manufacturer
-
It is used topically for the treatment of inflammatory and itchy skin diseases that respond to corticosteroids, such as atopic dermatitis, contact dermatitis, or psoriasis.
Dosage form: ointment
Active substance Dosage alclometasone dipropionate 0.5 mg/g ATC: D07AB10
-
It is intended for the topical treatment of inflammatory and itchy skin diseases that respond to steroids, such as psoriasis, atopic dermatitis, and contact dermatitis.
Dosage form: cream
Active substance Dosage alclometasone dipropionate 0.5 mg/g ATC: D07AB10
-
The medicine is used topically for the treatment of inflammatory and itchy skin diseases that respond to corticosteroids, such as atopic dermatitis, contact dermatitis, and psoriasis.
Dosage form: cream
Active substance Dosage alclometasone dipropionate 0.5 mg/g ATC: D07AB10
-
It is intended for the topical treatment of inflammatory skin diseases that cause itching and respond to corticosteroid treatment.
Dosage form: cream
Active substance Dosage betamethasone 0.5 mg/g ATC: D07AC01
-
The medicine is used topically for the treatment of skin diseases characterized by inflammation and itching, which respond to corticosteroid treatment.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g ATC: D07AC01
-
It is used topically for the treatment of skin diseases characterized by inflammation and itching, which respond to corticosteroid treatment.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g ATC: D07AC01
-
The medicine is used for the topical treatment of skin diseases complicated by bacterial infection and responsive to corticosteroid treatment. It is intended for persons over 13 years of age.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g gentamicin 1 mg/g ATC: D07CC01
-
It is used for the topical treatment of skin diseases that are complicated by bacterial infection and respond to corticosteroid treatment. It is intended for individuals over 13 years of age.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g gentamicin 1 mg/g ATC: D07CC01
-
The medicine is used for the topical treatment of skin diseases that respond to corticosteroid treatment and are additionally complicated by bacterial infection. It is intended for individuals over 13 years of age.
Dosage form: cream
Active substance Dosage betamethasone 0.5 mg gentamicin 1 mg ATC: D07CC01
-
The medicine is used topically for the treatment of skin diseases complicated by bacterial infection and responsive to corticosteroid treatment. It is intended for individuals over 13 years of age.
Dosage form: ointment
Active substance Dosage betamethasone 0,5 mg/g gentamicin 1 mg/g ATC: D07CC01
-
The medicine is used topically for the treatment of skin diseases complicated by bacterial infection that respond to corticosteroid treatment. It is intended for individuals over 13 years of age.
Dosage form: cream
ATC: D07CC01
-
The medicine is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: solution for skin
Active substance Dosage betamethasone 0.5 mg salicylic acid 20 mg ATC: D07XC01
-
The medicine is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg salicylic acid 30 mg ATC: D07XC01
-
The medicine is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 30 mg/g ATC: D07XC01
-
The ointment is intended for the topical treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 30 mg/g ATC: D07XC01
-
It is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: solution, topical
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 20 mg/g ATC: D07XC01
-
The medicinal product is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 30 mg/g ATC: D07XC01
-
The medicine is used topically to treat skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: solution, topical
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 20 mg/g ATC: D07XC01